Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Am J Kidney Dis. 2016 Mar 3;68(1):68–76. doi: 10.1053/j.ajkd.2016.01.015

Table 4.

C statistics, Likelihood Ratio Test P-Values, and the 2.5-Year RIDI and Continuous NRI for Multivariable Models with eGFRcr and with the 4-marker Composite Score

Outcome C statistic
With eGFR
C statistic With
4-marker
Composite
Difference in C-
statistic (95% CI)
Likelihood
Ratio Test
P-Value
RIDI (95% CI) Continuous NRI
(95% CI)
ESRD 0.888 0.895 0.007 (0.004–0.010) <0.001 0.026 (0.006–0.047) 0.252 (0.130–0.374)
All-cause Mortality 0.744 0.770 0.026 (0.017–0.036) <0.001 0.233 (0.162–0.304) 0.446 (0.304–0.588)
Cardiovascular Events 0.765 0.780 0.015 (0.004–0.025) <0.001 0.185 (0.094–0.276) 0.392 (0.216–0.567)

Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; HR, hazard ratio; RIDI, relative integrated discrimination improvement; mGFR, measured glomerular filtration rate; NRI, net reclassification improvement.

Note: Multivariable models adjusted for age, sex, race/ethnicity, diabetes, hypertension, prevalent cardiovascular disease, smoking status, high density lipoprotein cholesterol, natural log-transformed C-reactive protein, natural log transformed urinary albumin-creatinine ratio